|

Lenalidomide (Revlimid) Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Second Affiliated Hospital, School of Medicine, Zhejiang University1
  • Intergroupe Francophone du Myelome1

Indications

  • Cancer2
  • Solitary Plasmacytoma1
  • Multiple Myeloma, Newly Diagnosed1

Other2 trials

Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients
Phase 3
SBRT Plus Lenalidomide for Solitary Plasmacytoma: Phase II Trial
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.